Tonix Pharmaceuticals (TNXP) SEC Filings & 10K Form

$0.16
0.00 (0.00%)
(As of 04/23/2024 ET)

Recent Tonix Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/15/2024
3:49 PM
Tonix Pharmaceuticals (Filer)
Form ARS
04/15/2024
3:38 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
04/05/2024
3:47 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
03/29/2024
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
03/29/2024
4:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:03 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
8:23 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
8:48 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:01 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4/A
03/06/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:05 PM
SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:06 PM
MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:07 PM
SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:08 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:31 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:53 PM
Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
01/08/2024
4:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:33 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
01/02/2024
3:15 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
12/26/2023
4:25 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
12/21/2023
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:15 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
9:31 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
4:14 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
6:10 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:23 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him
11/09/2023
3:27 PM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
6:49 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2023
6:17 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
3:53 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
10/20/2023
4:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
3:32 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
3:15 PM
Tonix Pharmaceuticals (Filer)
Form 424B4
09/29/2023
3:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:35 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:36 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
7:28 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:15 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
7:31 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
6:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
6:51 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
6:15 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
7:35 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
7:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
6:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
4:24 PM
Tonix Pharmaceuticals (Filer)
Form 8-K/A
07/17/2023
6:12 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
4:05 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
7:17 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:12 PM
Tonix Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/15/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
4:29 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
6:01 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
4:13 PM
GRANGE DAVID L (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
4:14 PM
Bell Margaret Smith (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
4:15 PM
BAGGER RICHARD H (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2023
12:05 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him
05/04/2023
6:53 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
6:26 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TNXP) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners